Treatments - National Multiple Sclerosis Society

Skip to navigation Skip to content

Treatments

Share

Featured Video

MS treatments: understanding your options

Featuring: Dr. Benjamin Segal, Dr. George Kraft, Dr. Aliza Ben-Zacharia, and Dr. Susan Bennett

*This video was produced prior to approval of the latest disease modifying therapies Aubagio® & Tecfidera®. To learn about these new therapies, please watch the videos below. 

  1. What You Need To Know About Tecfidera® (video)

    What is Tecfidera® (dimethyl fumarate), formerly known as BG-12? Clinical trial findings; Potential side effects. Featuring: Bruce Cohen, MD and Gabriel Pardo, MD. Part one of one: 12 minutes

  2. What You Need To Know About Aubagio® (video)

    Dr. Jim Bowen and Dr. Lily Jung Henson discuss disease-modifying treatment, Aubagio® (teriflunomide).

  3. MS Treatments-Understanding Your Options (video)

    Featuring: Dr. Benjamin Segal, Dr. George Kraft, Dr. Aliza Ben-Zacharia, and Dr. Susan Bennett Discusses the following: Can exacerbations be managed? Disease-modifying therapies Symptom management The role of rehabilitation Complementary medicine

  4. MS Treatments-Disease Modifying Therapies, Part One (video)

    Featuring: Dr. Benjamin Segal, Dr. George Kraft and Dr. Aliza Ben-Zacharia This video was produced prior to approval of the latest disease modifying therapies Aubagio® & Tecfidera®. To learn about these new therapies, please watch the videos above.

  5. MS Treatments-Disease Modifying Therapies, Part Two (video)

    Featuring: Dr. Benjamin Segal, Dr. George Kraft, Dr. Aliza Ben-Zacharia, and Dr. Susan Bennett Discusses the following: Can exacerbations be managed? Disease-modifying therapies Symptom management The role of rehabilitation Complementary medicine This video was produced prior to approval of the latest disease modifying therapies Aubagio® & Tecfidera®. To learn about these new therapies, please watch the videos above.

  6. Gilenya What Is It And How Does It Work (video)

    Part one of a two-part interview with Aaron Miller, MD, who discusses Gilenya, a new oral therapy for multiple sclerosis. Dr. Miller explains how the medication works, clinical trials findings, and potential side effects.

  7. Gilenya Information To Consider (video)

    Part two of a two-part interview with Aaron Miller, MD, who discusses Gilenya, an oral therapy for multiple sclerosis. Dr. Miller talks about who can take Gilenya, cost and availability.

  8. Ampyra: Medication to Improve Walking (video)

    Patricia K. Coyle, MD, discusses Ampyra (formerly known as fampridine SR), a medication that may help people with multiple sclerosis to improve their walking.

  9. Tysabri: What You Need To Know The Basic Facts (video)

    Featuring John Richert, MD Topics include: History; Tysabri versus other drugs; Safeguards; Balancing risks and benefits

  10. Tysabri: What You Need To Know A Look At The Infusion Process (video)

    Featuring John Richert, MD Topics include: Touch Program; Infusion centers; Choosing Tysabri

  11. Making Treatment & Lifestyle Decisions: Thinking About Benefits & Risks (video)

    Explores the factors people must consider when making treatment and lifestyle decisions, including when to begin treatment, the role information overload can play in decision making, and how to weigh the benefits and risks of a treatment or lifestyle decision. Download a copy of the companion book and transcripts.

  12. Treatment Recommendations for Progressive MS (video)

    Explores the factors people must consider when making treatment and lifestyle decisions, including when to begin treatment, the role information overload can play in decision making, and how to weigh the benefits and risks of a treatment or lifestyle decision. Excerpt from 2013 North American Education Program.

  13. Shift in Doctor <-> Patient Relationship (video)

    Explores the factors people must consider when making treatment and lifestyle decisions, including when to begin treatment, the role information overload can play in decision making, and how to weigh the benefits and risks of a treatment or lifestyle decision. Excerpt from 2013 North American Education Program.

Share